
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Neogen Corporation (NEOG)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/29/2025: NEOG (2-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $6.5
1 Year Target Price $6.5
2 | Strong Buy |
0 | Buy |
1 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 10.57% | Avg. Invested days 36 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.25B USD | Price to earnings Ratio - | 1Y Target Price 6.5 |
Price to earnings Ratio - | 1Y Target Price 6.5 | ||
Volume (30-day avg) 3 | Beta 1.79 | 52 Weeks Range 3.87 - 17.95 | Updated Date 08/30/2025 |
52 Weeks Range 3.87 - 17.95 | Updated Date 08/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -5.03 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -122.06% | Operating Margin (TTM) -4.97% |
Management Effectiveness
Return on Assets (TTM) 0.01% | Return on Equity (TTM) -41.88% |
Valuation
Trailing PE - | Forward PE 16 | Enterprise Value 2014036819 | Price to Sales(TTM) 1.4 |
Enterprise Value 2014036819 | Price to Sales(TTM) 1.4 | ||
Enterprise Value to Revenue 2.25 | Enterprise Value to EBITDA 25.07 | Shares Outstanding 217204992 | Shares Floating 203588593 |
Shares Outstanding 217204992 | Shares Floating 203588593 | ||
Percent Insiders 0.85 | Percent Institutions 112.8 |
Upturn AI SWOT
Neogen Corporation

Company Overview
History and Background
Neogen Corporation was founded in 1982 in Lansing, Michigan. It has grown through strategic acquisitions and organic growth to become a leader in food and animal safety solutions.
Core Business Areas
- Food Safety: Develops and markets food safety diagnostic test kits and related products used by food manufacturers and processors to detect harmful bacteria, allergens, toxins, and other contaminants.
- Animal Safety: Develops and markets animal safety products, including veterinary instruments, pharmaceuticals, vaccines, and diagnostic products for the animal healthcare market.
Leadership and Structure
John Adent is the President and CEO. The company has a traditional corporate structure with various departments focused on sales, marketing, research and development, and operations.
Top Products and Market Share
Key Offerings
- AccuPoint Advanced Sanitation Monitoring System: A system for monitoring sanitation effectiveness in food processing facilities. Market share data is not publicly available. Competitors include Hygiena and 3M.
- Reveal 3-D for Total Aflatoxin: A rapid test kit for detecting aflatoxin in grains and other commodities. Market share data is not publicly available. Competitors include Charm Sciences and Romer Labs.
- Veterinary Instruments: A broad range of instruments used in veterinary practice. Market share data is not publicly available. Competitors include Jorgensen Laboratories and Patterson Veterinary.
Market Dynamics
Industry Overview
The food and animal safety industries are driven by increasing regulatory requirements, consumer demand for safe products, and advancements in diagnostic technology.
Positioning
Neogen is positioned as a leading provider of food and animal safety solutions, with a strong reputation for innovation and quality.
Total Addressable Market (TAM)
The global food safety testing market is estimated to reach $25.8 billion by 2028. Neogen holds a significant position within this market, focusing on rapid diagnostics and comprehensive solutions.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Wide range of products
- Extensive distribution network
- History of innovation
- Experienced Management Team
Weaknesses
- Reliance on acquisitions for growth
- Potential impact from regulatory changes
- Exposure to commodity price fluctuations
Opportunities
- Expanding into emerging markets
- Developing new diagnostic technologies
- Increasing demand for food and animal safety solutions
- Partnerships and collaborations with industry players
Threats
- Intense competition
- Economic downturns
- Changes in consumer preferences
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- 3M
- Danaher Corp (DHR)
- Thermo Fisher Scientific Inc (TMO)
- Idexx Laboratories Inc (IDXX)
Competitive Landscape
Neogen competes with larger, more diversified companies like 3M and Danaher. Neogen's focus on food and animal safety provides a competitive advantage in those specific markets.
Major Acquisitions
3M Food Safety
- Year: 2022
- Acquisition Price (USD millions): 5350
- Strategic Rationale: Expand Neogen's food safety diagnostics portfolio and global reach. This acquisition significantly increased Neogen's market share and product offerings.
Growth Trajectory and Initiatives
Historical Growth: Neogen has historically grown through acquisitions and organic growth in its core markets.
Future Projections: Analyst estimates suggest continued growth in the food and animal safety markets.
Recent Initiatives: Focus on expanding its genomics business and developing new diagnostic tests.
Summary
Neogen is a leading player in the food and animal safety industries, with a strong brand and a wide range of products. The acquisition of 3M Food Safety was significant, expanding its portfolio and reach. However, it faces intense competition and needs to manage integration risks effectively. Future success depends on continued innovation and expansion into new markets.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Market share data can vary and may be based on estimates.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Neogen Corporation
Exchange NASDAQ | Headquaters Lansing, MI, United States | ||
IPO Launch date 1989-08-23 | CEO, President & Director Mr. Mike Nassif | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 2974 | Website https://www.neogen.com |
Full time employees 2974 | Website https://www.neogen.com |
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.